Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hemminki K, Li X, Försti A, Sundquist J, Sundquist K . Incidence and survival in non-hereditary amyloidosis in Sweden. BMC Public Health 2012; 12: 974.

    Article  Google Scholar 

  2. Merlini G, Seldin DC, Gertz MA . Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol 2011; 29: 1924–1933.

    Article  Google Scholar 

  3. Kyle RA, Rajkumar SV . Epidemiology of the plasma-cell disorders. Best Pract Res Clin Haematol 2007; 20: 637–664.

    Article  CAS  Google Scholar 

  4. Morgan GJ, Johnson DC, Weinhold N, Goldschmidt H, Landgren O, Lynch HT et al. Inherited genetic susceptibility to multiple myeloma. Leukemia 2014; 28: 518–524.

    Article  CAS  Google Scholar 

  5. Bochtler T, Hegenbart U, Heiss C, Benner A, Moos M, Seckinger A et al. Hyperdiploidy is less frequent inAL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14). Blood 2011; 117: 3809–3815.

    Article  CAS  Google Scholar 

  6. Broderick P, Chubb D, Johnson DC, Weinhold N, Försti A, Lloyd A et al. Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk. Nat Genet 2012; 44: 58–61.

    Article  CAS  Google Scholar 

  7. Chubb D, Weinhold N, Broderick P, Chen B, Johnson DC, Försti A et al. Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. Nat Genet 2013; 45: 1221–1225.

    Article  CAS  Google Scholar 

  8. Weinhold N, Johnson DC, Rawstron AC, Försti A, Doughty C, Vijayakrishnan J et al. Inherited genetic susceptibility to monoclonal gammopathy of unknown significance. Blood 2014; 123: 2513–2517.

    Article  CAS  Google Scholar 

  9. Weinhold N, Johnson DC, Chubb D, Chen B, Försti A, Hosking FJ et al. The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. Nat Genet 2013; 45: 522–525.

    Article  CAS  Google Scholar 

  10. Schoenland SO, Hegenbart U, Bochtler T, Mangatter A, Hansberg M, Ho AD et al. Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients. Blood 2012; 119: 488–493.

    Article  CAS  Google Scholar 

  11. Kourelis TV, Kumar SK, Gertz Ma, Lacy MQ, Buadi FK, Hayman SR et al. Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis. J Clin Oncol 2013; 31: 4319–4324.

    Article  CAS  Google Scholar 

  12. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES . Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 2006; 25: 1620–1628.

    Article  CAS  Google Scholar 

  13. Li Z, Jiao X, Wang C, Shirley LA, Elsaleh H, Dahl O et al. Alternative cyclin D1 splice forms differentially regulate the DNA damage response. Cancer Res 2010; 70: 8802–8811.

    Article  CAS  Google Scholar 

  14. Jirawatnotai S, Hu Y, Michowski W, Elias JE, Becks L, Bienvenu F et al. A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature 2011; 474: 230–234.

    Article  CAS  Google Scholar 

  15. Hemminki K, Musak L, Vymetalkova V, Smerhovsky Z, Halasova E, Osina O et al. Cyclin D1 splice site variant triggers chromosomal aberrations in healthy humans. Leukemia 2014; 28: 721–722.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Funding was provided to Dietmar-Hopp-Stiftung in Walldorf, The German Ministry of Education and Science (Gliommics 01ZX1309B), the German Cancer Aid no. 110131, GERAMY (BMBF 01GM1107A) and the University Hospital Heidelberg. Additional funding was also provided by the German Ministry of Education and Science and the German Research Council (DFG; Projects SI 236/8-1, SI236/9-1 and ER 155/6-1).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N Weinhold.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weinhold, N., Försti, A., da Silva Filho, M. et al. Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma. Leukemia 28, 2254–2256 (2014). https://doi.org/10.1038/leu.2014.208

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2014.208

This article is cited by

Search

Quick links